Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia

Schizophrenia Research

Volumn 132, Issue 1, 2011, Pages 50-53

  Pedersen, Cort A ^a   Gibson, Clare M ^b   Rau, Shane W ^a   Salimi, Kayvon ^a   Smedley, Kelly L ^a   Casey, Robin L ^a   Leserman, Jane ^a   Jarskog, L Fredrik ^a   Penn, David L ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

Oxytocin; Psychosis; Schizophrenia; Social cognition; Social perception; Theory of Mind

Indexed keywords

OXYTOCIN; PLACEBO;

ADULT; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SELF ADMINISTRATION; ELECTROCARDIOGRAM; FEMALE; HUMAN; LIVER FUNCTION; MALE; MORNING DOSAGE; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SIDE EFFECT; SOCIAL COGNITION; THEORY OF MIND; UREA NITROGEN BLOOD LEVEL; URINALYSIS; VITAL SIGN;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OXYTOCIN; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL PERCEPTION; THEORY OF MIND; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052638461     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.07.027     Document Type: Article

References (24)

1. Adolphs R., Tranel D., Damasio A.R. The human amygdala in social judgment. Nature 1998, 393:470-474.
2. Born J., Lange T., Kern W., McGregor G.P., Bickel U., Fehm H.L. Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. 2002, 5:514-516.
3. Brüne M. Social cognition and behaviour in schizophrenia. The Social Brain-Evolution and Pathology 2003, 277-313. John Wiley & Sons, Chichester. M. Brüne, H. Ribbert, W. Schiefenhövel (Eds.).
4. Brüne M. Emotion recognition, "theory of mind", and social behavior in schizophrenia. Psychiatry Res. 2005, 133:135-147.
5. Caldwell H.K., Stephens S.L., Young W.S.I.I.I. Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice. Mol. Psychiatry 2009, 14:190-196.
6. Carter C.S., Lederhendler I., Kirkpatrick B. The Integrative Neurobiology of Affiliation 1998, MIT Press, Cambridge, MA.
7. Couture S.M., Penn D.L., Roberts D.L. The functional significance of social cognition in schizophrenia: a review. Schizophr. Bull. 2006, 32(1):S44-SS63.
8. Feifel D., Reza T. Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating. Psychopharmacology (Berl.) 1999, 141:93-98.
9. Feifel D., MacDonald K., Nguyen A., Cobb P., Warlan H., Galangue B., Minassian A., Becker O., Cooper J., Perry W., Lefebvre M., Gonzalez J., Hadley A. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol. Psychiatry 2010, 68:678-680.
10. Fenigstein A., Vanable P. Persecutory ideation and self consciousness. J. Pers. Soc. Psych. 1992, 62:129-138.
11. Fett A.J., Viechtbauer W., Dominguez M., Penn D.L., van Os J., Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci. Biobehav. Rev. 2011, 35:573-588.
12. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 2001, 81:629-683.
13. Green M.F., Olivier B., Crawley J.N., Penn D.L., Silverstein S. Social cognition in schizophrenia: recommendations from the MATRICS New Approaches Conference. Schizophr. Bull. 2005, 31:882-887.
14. Horan W.P., Kern R.S., Green M.F., Penn D.L. Social cognition training for individuals with schizophrenia: emerging evidence. Am. J. Psychiatric Rehab. 2008, 11(3):205-252.
15. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
16. Keri S., Kiss I., Kelemen O. Sharing secrets: oxytocin and trust in schizophrenia. Soc. Neurosci. 2009, 4:287-293.
17. Lee P.R., Brady D.L., Shapiro R.A., Dorsa D.M., Koenig J.I. Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology 2005, 30:1883-1894.
18. Lee P.R., Brady D.L., Shapiro R.A., Dorsa D.M., Koenig J.I. Prenatal stress generates deficits in rat social behavior: reversal by oxytocin. Brain Res. 2007, 1156:152-167.
19. Lee H.-J., Macbeth A.H., Pagani J.H., Young W.S.I.I.I. Oxytocin: the great facilitator of life. Prog. Neurobiol. 2009, 88:127-151.
20. MacDonald K., MacDonald T.M. The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. Harv. Rev. Psychiatry 2010, 18:1-21.
21. Pedersen C.A., Caldwell J.D., Jirikowski G.F., Insel T.R. Oxytocin in maternal, sexual and social behaviors. Ann. N. Y. Acad. Sci. 1992, 652.
22. Penn D.L., Keefe R.S., Davis S.M., Meyer P.S., Perkins D.O., Losardo D., Lieberman J.A. The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial. Schizophr. Res. 2009, 115(1):17-23.
23. Roberts D.L., Penn D.L., Labate D., Margolis S.A., Sterne A. Transportability and feasibility of Social Cognition And Interaction Training (SCIT) in community settings. Behav. Cogn. Psychother. 2010, 38:35-47.
24. Rubin L.H., Carter C.S., Drogos L., Pournajafi-Nazarloo H., Sweeney J.A., Maki P.M. Peripheral oxytocin is associated with reduced symptom severity in schizophrenia. Schizophr. Res. 2010, 124:13-21.